WO1997012036A3 - Bone stimulating factor - Google Patents
Bone stimulating factor Download PDFInfo
- Publication number
- WO1997012036A3 WO1997012036A3 PCT/CA1996/000653 CA9600653W WO9712036A3 WO 1997012036 A3 WO1997012036 A3 WO 1997012036A3 CA 9600653 W CA9600653 W CA 9600653W WO 9712036 A3 WO9712036 A3 WO 9712036A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ile
- lys
- asp
- ser
- thr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU70811/96A AU7081196A (en) | 1995-09-26 | 1996-09-26 | Bone stimulating factor |
JP9513029A JPH11514858A (en) | 1995-09-26 | 1996-09-26 | Bone stimulating factor |
EP96931700A EP0853667A2 (en) | 1995-09-26 | 1996-09-26 | Bone stimulating factor |
US09/229,304 US6693081B2 (en) | 1995-09-26 | 1999-01-13 | Bone stimulating factor |
US10/718,526 US20040147450A1 (en) | 1995-09-26 | 2003-11-24 | Bone stimulating factor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US431495P | 1995-09-26 | 1995-09-26 | |
US60/004,314 | 1995-09-26 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US4805898A Continuation | 1995-09-26 | 1998-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997012036A2 WO1997012036A2 (en) | 1997-04-03 |
WO1997012036A3 true WO1997012036A3 (en) | 1997-06-05 |
Family
ID=21710157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA1996/000653 WO1997012036A2 (en) | 1995-09-26 | 1996-09-26 | Bone stimulating factor |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0853667A2 (en) |
JP (1) | JPH11514858A (en) |
AU (1) | AU7081196A (en) |
WO (1) | WO1997012036A2 (en) |
ZA (1) | ZA968062B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6693081B2 (en) * | 1995-09-26 | 2004-02-17 | Osteopharm Inc. | Bone stimulating factor |
WO2000075185A1 (en) * | 1999-06-02 | 2000-12-14 | Osteopharm Inc. | Bone stimulating factor |
FR2811991B1 (en) * | 2000-07-19 | 2003-01-17 | Univ Bordeaux 1 | PF-4 MUTE, ITS FRAGMENTS AND MUTED FUSION PEPTIDES, THEIR ANALOGS, THE CORRESPONDING DNA, DNA AND CDNA SEQUENCES, AND THEIR USE IN THE INHIBITION OF ANGIOGENESIS |
US7399826B1 (en) | 2003-10-02 | 2008-07-15 | Ali Sadat M | Peptide for promoting healing of fractures |
DE102019207859A1 (en) * | 2018-12-21 | 2020-06-25 | Gelita Ag | Synthetic and recombinantly produced collagen peptides with biological effectiveness |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005309A1 (en) * | 1992-08-28 | 1994-03-17 | University Of Louisville Research Foundation, Inc. | Use of platelet factor 4 to inhibit osteoblast proliferation |
WO1995028172A1 (en) * | 1994-04-18 | 1995-10-26 | Osteopharm Limited | Human bone stimulating factor |
-
1996
- 1996-09-25 ZA ZA968062A patent/ZA968062B/en unknown
- 1996-09-26 JP JP9513029A patent/JPH11514858A/en active Pending
- 1996-09-26 EP EP96931700A patent/EP0853667A2/en not_active Withdrawn
- 1996-09-26 WO PCT/CA1996/000653 patent/WO1997012036A2/en not_active Application Discontinuation
- 1996-09-26 AU AU70811/96A patent/AU7081196A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005309A1 (en) * | 1992-08-28 | 1994-03-17 | University Of Louisville Research Foundation, Inc. | Use of platelet factor 4 to inhibit osteoblast proliferation |
US5304542A (en) * | 1992-08-28 | 1994-04-19 | University Of Louisville Research Foundation, Inc. | Use of platelet factor 4 to inhibit osteoblast proliferation |
WO1995028172A1 (en) * | 1994-04-18 | 1995-10-26 | Osteopharm Limited | Human bone stimulating factor |
Non-Patent Citations (1)
Title |
---|
JAN E. EHLERT ET AL.: "Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2)", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 11, 17 March 1995 (1995-03-17), MD US, pages 6338 - 6344, XP002022825 * |
Also Published As
Publication number | Publication date |
---|---|
WO1997012036A2 (en) | 1997-04-03 |
JPH11514858A (en) | 1999-12-21 |
EP0853667A2 (en) | 1998-07-22 |
AU7081196A (en) | 1997-04-17 |
ZA968062B (en) | 1997-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor | |
ZA943464B (en) | Vascular endothelial growth factor 2 | |
EP1063293A3 (en) | Transforming growth factor alpha H1 | |
NL300013I2 (en) | New proteins with TNF inhibitory effect and their preparation. | |
MD1652G2 (en) | Protein possessing the cytokin - type activity, recombinant DNA-codifyer for such protein, transformed cells and microorganism, expression vector, process for protein obtaining and remedy containing such a protein | |
NZ279963A (en) | Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946 | |
WO1996019580A3 (en) | Telomerase protein component | |
WO2000053749A3 (en) | Vascular adhesion molecules and modulation of their function | |
NO975565L (en) | Leg stimulating factor | |
WO1997012036A3 (en) | Bone stimulating factor | |
US5136023A (en) | Polypeptide with cell-spreading activity | |
NZ334714A (en) | Liver proteins as agents against autoimmune diseases | |
BG105682A (en) | Bone stimulating factor | |
CA2077590A1 (en) | Recombinant dna coding for a protein with endochitinase activity | |
AU1444699A (en) | Single-chain polypeptides comprising troponin i and troponin | |
HUP9702500A2 (en) | Anti-obesity proteins | |
IL115825A0 (en) | Therapeutic protein | |
WO1994029447A3 (en) | Dna coding for the human thyrotropin-releasing hormone receptor | |
AU8302791A (en) | Recombinant gene coding for a protein having an endochitinase activity | |
EP0723014A3 (en) | cDNA of DOCK180 gene and DOCK180 protein | |
Ivanov et al. | COMPOSITION OF SLIGHTLY SOLUBLE AGGREGATES ISOLATED FROM BLOOD SERUM OF CANCEROUS PATIENTS | |
HU211309A9 (en) | Novel polipeptide and production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1997 513029 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996931700 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996931700 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996931700 Country of ref document: EP |